Literature DB >> 23727748

Hypertension-associated expenditures for medication among US adults.

Guijing Wang1, Lili Yan2, Carma Ayala2, Mary G George2, Jing Fang2.   

Abstract

BACKGROUND: We sought to estimate how much the presence of hypertension adds to annual per capita and total expenditures for medication among US adults.
METHODS: The sample included 21,782 civilian noninstitutionalized adults aged ≥ 18 years who participated in the 2007 Medical Expenditure Panel Survey. Hypertension was defined as having a diagnosis of high blood pressure (except during pregnancy) or taking a blood pressure medication. We used a 2-part model to examine all-cause medication expenditure associated with hypertension.
RESULTS: The prevalence of hypertension was 32.2%. Overall, 66.7% of adults purchased prescribed medications, with this proportion higher among hypertensive (93.0%) than normotensive (54.4%) adults (P < 0.001). Hypertensive adults were more likely to have medication expenditures than were normotensive adults (odds ratio (OR) = 6.42; P < 0.001). Among hypertensive adults, those aged ≥ 45 years were more likely to incur medication expenditure than those aged 18-44 years (OR = 3.00, P < 0.001 for those aged 45-64 years; OR = 5.95, P < 0.001 for those aged ≥ 65 years), whereas women were 2.91 times as likely as men to have medication spending (P < 0.001). Hispanics were less likely than non-Hispanic whites to have such spending (OR = 0.51; P < 0.001). Among those purchasing medications, the average cost was $1,510 higher among hypertensive persons ($2,337) than normotensive persons ($827). Hypertension-associated expenditures for medication were estimated at $68 billion in the US civilian non-institutionalized population in 2007.
CONCLUSIONS: The presence of hypertension among US adults is associated with an increase of all-cause expenditures for medication, with this increase varying across groups by age and sex. © Published by Oxford University Press on behalf of American Journal of Hypertension Ltd 2013. This work is written by (a) US Government employees(s) and is in the public domain in the US.

Entities:  

Keywords:  blood pressure; drug cost; economics; high blood pressure; hypertension.

Mesh:

Substances:

Year:  2013        PMID: 23727748      PMCID: PMC4544731          DOI: 10.1093/ajh/hpt079

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  26 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Generalized modeling approaches to risk adjustment of skewed outcomes data.

Authors:  Willard G Manning; Anirban Basu; John Mullahy
Journal:  J Health Econ       Date:  2005-05       Impact factor: 3.883

3.  A robust approach for skewed and heavy-tailed outcomes in the analysis of health care expenditures.

Authors:  Eva Cantoni; Elvezio Ronchetti
Journal:  J Health Econ       Date:  2006-01-04       Impact factor: 3.883

4.  Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.

Authors:  Armando Arredondo; Alexis Zúñiga
Journal:  Am J Hypertens       Date:  2006-06       Impact factor: 2.689

5.  Hypertension in adults across the age spectrum: current outcomes and control in the community.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Daniel Levy
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

6.  Gender disparities in medical expenditures attributable to hypertension in the United States.

Authors:  Rituparna Basu; Luisa Franzini; Patrick M Krueger; David R Lairson
Journal:  Womens Health Issues       Date:  2010 Mar-Apr

7.  Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-02-04       Impact factor: 17.586

8.  Hospitalization costs associated with hypertension as a secondary diagnosis among insured patients aged 18-64 years.

Authors:  Guijing Wang; Zefeng Zhang; Carma Ayala
Journal:  Am J Hypertens       Date:  2009-12-10       Impact factor: 2.689

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  8 in total

1.  Disparities in access to care among US adults with self-reported hypertension.

Authors:  Jing Fang; Quanhe Yang; Carma Ayala; Fleetwood Loustalot
Journal:  Am J Hypertens       Date:  2014-05-21       Impact factor: 2.689

2.  Racial/Ethnic differences in medication uptake and clinical outcomes among hospitalized cardiovascular patients with hypertension and diabetes.

Authors:  Heidi Mochari-Greenberger; Lori Mosca
Journal:  Am J Hypertens       Date:  2014-06-05       Impact factor: 2.689

Review 3.  The global epidemiology of hypertension.

Authors:  Katherine T Mills; Andrei Stefanescu; Jiang He
Journal:  Nat Rev Nephrol       Date:  2020-02-05       Impact factor: 28.314

4.  Expenditures of medicine use in hypertensive/diabetic elderly and physical activity and engagement in walking: cross secctional analysis of SABE Survey.

Authors:  Denise Rodrigues Bueno; Maria de Fátima Nunes Marucci; Luis Alberto Gobbo; Manuela de Almeida-Roediger; Yeda Aparecida de Oliveira Duarte; Maria Lucia Lebrão
Journal:  BMC Geriatr       Date:  2017-03-20       Impact factor: 3.921

5.  The relationship between the blood pressure responses to exercise following training and detraining periods.

Authors:  Emily A Moker; Lori A Bateman; William E Kraus; Linda S Pescatello
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

6.  Medical Expenditures Associated With Hypertension in the U.S., 2000-2013.

Authors:  Donglan Zhang; Guijing Wang; Ping Zhang; Jing Fang; Carma Ayala
Journal:  Am J Prev Med       Date:  2017-12       Impact factor: 5.043

7.  Annual Total Medical Expenditures Associated with Hypertension by Diabetes Status in U.S. Adults.

Authors:  Guijing Wang; Xilin Zhou; Xiaohui Zhuo; Ping Zhang
Journal:  Am J Prev Med       Date:  2017-12       Impact factor: 5.043

8.  Comorbidity Status and Annual Total Medical Expenditures in U.S. Hypertensive Adults.

Authors:  Chanhyun Park; Jing Fang; Nikki A Hawkins; Guijing Wang
Journal:  Am J Prev Med       Date:  2017-12       Impact factor: 5.043

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.